Interleukin-2 Postremission Therapy in Acute Myeloid Leukemia (AML): In Vitro and In Vivo Effects of a Five Day Continuous Infusion of IL-2 on Phenotype and Function of Peripheral Lymphocytes

H.S.P. Garritsen, C. Constantin, F. Griesinger, A. Kolkmeyer, R.M.P. Doornbos, B.G. de Grooth, Jan Greve, B. Wormann, W. Hiddemann

    Research output: Other contributionOther research output

    Original languageUndefined
    Publication statusPublished - 1 Jun 1996


    • METIS-131500

    Cite this